US 9,173,862 B2Granted

Methods and compositions for treating and identifying compounds to treat age-related macular degeneration

AssigneeArizona Board of Regents, a Body Corporate of the State of Arizona, Acting for and on Behalf of the University of Arizona

InventorsBrian McKay, John A. Martens

Life of this patent

Estimating the term…

Abstract

The present invention provides methods for treating or limiting development of age-related macular degeneration, as well as methods for identifying compound suitable for such use.

Claims16

Dependent claims

A method for treating age-related macular degeneration (AMD), comprising administering to a subject with AMD an amount of an agonist of the OA1 receptor selected from the group consisting of L-DOPA, an L-DOPA analogue, and pharmaceutically acceptable salts thereof, effective for treating AMD.

Dependencies are inferred from the claim text.

Facts

Application: 12/937,669Filed 17 Apr 2009 · us provisional application
Priority: 18 Apr 2008
Published: US 2011/0044908 A124 Feb 2011
Granted: 3 Nov 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification20 codes

A61K 31/198
The amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine,…:…
A61K 31/00
Medicinal preparations containing organic active ingredients
A61K 31/07
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates: retinol compounds, e.g. vitamin A
A61K 31/195
Carboxylic acids, e.g. valproic acid: having an amino group

Family

Application61/124,624Us provisional application · filed 18 Apr 2008
US 2011/0044908 A1Pre-grant publication · published 24 Feb 2011
US 9,173,862 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results